Determining the genetic contribution to autoimmune thyroid disease has helped unravel how immune disruption leads to disease onset. Breakthroughs in genome-wide association studies have facilitated screening of a greater proportion of the genome. This Review will focus on the new susceptibility loci identified by genome-wide association studies and what insights these loci provide into disease pathogenesis.
